NO20081045L - Forbindelser og fremgangsmater for behandling av cancer - Google Patents
Forbindelser og fremgangsmater for behandling av cancerInfo
- Publication number
- NO20081045L NO20081045L NO20081045A NO20081045A NO20081045L NO 20081045 L NO20081045 L NO 20081045L NO 20081045 A NO20081045 A NO 20081045A NO 20081045 A NO20081045 A NO 20081045A NO 20081045 L NO20081045 L NO 20081045L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- methods
- treating cancer
- leukemia
- potent
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001495 arsenic compounds Chemical class 0.000 abstract 1
- 210000000601 blood cell Anatomy 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 229940093920 gynecological arsenic compound Drugs 0.000 abstract 1
- 230000002489 hematologic effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/66—Arsenic compounds
- C07F9/70—Organo-arsenic compounds
- C07F9/72—Aliphatic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70416305P | 2005-07-29 | 2005-07-29 | |
| PCT/US2006/029835 WO2007027344A2 (en) | 2005-07-29 | 2006-07-28 | Compounds and methods for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081045L true NO20081045L (no) | 2008-04-25 |
Family
ID=37809342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081045A NO20081045L (no) | 2005-07-29 | 2008-02-28 | Forbindelser og fremgangsmater for behandling av cancer |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7968738B2 (https=) |
| EP (2) | EP1919564B1 (https=) |
| JP (1) | JP4994374B2 (https=) |
| AU (1) | AU2006285329B2 (https=) |
| CA (1) | CA2617049A1 (https=) |
| ES (2) | ES2532666T3 (https=) |
| NO (1) | NO20081045L (https=) |
| WO (1) | WO2007027344A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2532666T3 (es) | 2005-07-29 | 2015-03-30 | Solasia Pharma K.K. | Compuestos y métodos para el tratamiento del cáncer |
| TW200829261A (en) | 2006-09-29 | 2008-07-16 | Ziopharm Oncology Inc | Method for controlling angiogenesis in animals |
| KR20100100835A (ko) | 2007-11-02 | 2010-09-15 | 지오팜 온콜로지 인코포레이티드 | 유기 비소제와의 병용 요법 |
| SG186599A1 (en) * | 2007-12-12 | 2013-01-30 | Ziopharm Oncology Inc | Compounds and methods for the treatment of cancer |
| RU2534606C2 (ru) * | 2008-08-20 | 2014-11-27 | Зайофарм Онколоджи, Инк. | Мышьякорганические соединения и способы лечения рака |
| WO2014045083A1 (en) | 2012-09-20 | 2014-03-27 | Bendale Yogesh Narayan | Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancers |
| TWI617305B (zh) * | 2013-12-05 | 2018-03-11 | 蘇愛康制藥有限公司 | 治療癌症的化合物及其應用程序 |
| BR112017018772B1 (pt) * | 2015-03-12 | 2021-09-21 | Km Biologics Co., Ltd. | Material antiadesão, método para a preparação e kit do referido material e biomembrana substituta, método para a preparação e kit da referida membrana |
| CN107167433A (zh) * | 2016-03-07 | 2017-09-15 | 天津国际生物医药联合研究院 | 一种检测氯二甲基砷的方法 |
| JPWO2019220961A1 (ja) * | 2018-05-18 | 2020-05-28 | ソレイジア・ファーマ株式会社 | ダリナパルシンのアルカリ金属塩及び／又は無機酸付加塩の結晶型及びその製剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
| JP2001519366A (ja) * | 1997-10-15 | 2001-10-23 | ポーラクス バイオファーマシュティカルズ，インコーポレーテッド | ヒ素化合物を用いた、原発性および転移性の腫瘍性疾患を治療するための組成物および方法 |
| IL136051A0 (en) * | 1997-11-10 | 2001-05-20 | Sloan Kettering Inst Cancer | Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| JP2001525371A (ja) * | 1997-12-05 | 2001-12-11 | イーライ・リリー・アンド・カンパニー | Ｇｌｐ−１製剤 |
| CN1233476A (zh) * | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
| SE9802080D0 (sv) * | 1998-06-11 | 1998-06-11 | Hellstroem | Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| EP1002537A1 (en) | 1998-10-30 | 2000-05-24 | Assistance Publique, Hopitaux De Paris | Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma |
| US6191123B1 (en) * | 1999-03-19 | 2001-02-20 | Parker Hughes Institute | Organic-arsenic compounds |
| EP1328253B1 (en) * | 2000-04-26 | 2006-03-22 | Oregon Health Sciences University | Administration of a thiol-based chemoprotectant compound |
| US6911471B2 (en) | 2002-01-07 | 2005-06-28 | The Texas A&M University System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| TWI411431B (zh) * | 2004-07-16 | 2013-10-11 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
| ES2532666T3 (es) | 2005-07-29 | 2015-03-30 | Solasia Pharma K.K. | Compuestos y métodos para el tratamiento del cáncer |
| KR20100100835A (ko) * | 2007-11-02 | 2010-09-15 | 지오팜 온콜로지 인코포레이티드 | 유기 비소제와의 병용 요법 |
-
2006
- 2006-07-28 ES ES11180330.0T patent/ES2532666T3/es active Active
- 2006-07-28 US US11/495,172 patent/US7968738B2/en active Active
- 2006-07-28 EP EP06824793.1A patent/EP1919564B1/en active Active
- 2006-07-28 ES ES06824793T patent/ES2531159T3/es active Active
- 2006-07-28 WO PCT/US2006/029835 patent/WO2007027344A2/en not_active Ceased
- 2006-07-28 CA CA002617049A patent/CA2617049A1/en not_active Abandoned
- 2006-07-28 EP EP11180330.0A patent/EP2394702B1/en not_active Not-in-force
- 2006-07-28 JP JP2008524273A patent/JP4994374B2/ja active Active
- 2006-07-28 AU AU2006285329A patent/AU2006285329B2/en not_active Ceased
-
2008
- 2008-02-28 NO NO20081045A patent/NO20081045L/no not_active Application Discontinuation
-
2011
- 2011-06-01 US US13/150,516 patent/US8334398B2/en active Active
-
2012
- 2012-11-14 US US13/676,929 patent/US8865764B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1919564A2 (en) | 2008-05-14 |
| US8334398B2 (en) | 2012-12-18 |
| EP2394702B1 (en) | 2014-12-31 |
| AU2006285329A1 (en) | 2007-03-08 |
| WO2007027344A2 (en) | 2007-03-08 |
| AU2006285329B2 (en) | 2012-10-04 |
| US20130142730A1 (en) | 2013-06-06 |
| JP2009502971A (ja) | 2009-01-29 |
| WO2007027344A3 (en) | 2007-12-21 |
| EP1919564B1 (en) | 2014-11-26 |
| ES2531159T3 (es) | 2015-03-11 |
| HK1164767A1 (en) | 2012-09-28 |
| AU2006285329A2 (en) | 2008-08-14 |
| CA2617049A1 (en) | 2007-03-08 |
| US20120022229A1 (en) | 2012-01-26 |
| US7968738B2 (en) | 2011-06-28 |
| EP2394702A1 (en) | 2011-12-14 |
| ES2532666T3 (es) | 2015-03-30 |
| JP4994374B2 (ja) | 2012-08-08 |
| HK1117780A1 (en) | 2009-01-23 |
| US8865764B2 (en) | 2014-10-21 |
| US20070183972A1 (en) | 2007-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081045L (no) | Forbindelser og fremgangsmater for behandling av cancer | |
| TW200616615A (en) | Compounds and methods for the treatment of cancer | |
| WO2011098262A3 (en) | P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth | |
| SG151267A1 (en) | Carboline derivatives useful in the inhibition of angiogenesis | |
| NO20075918L (no) | Substituerte pyrrolo-pyridiner, forbindelser inneholdende disse, fremgangsmate for deres fremstilling og anvendelse derav | |
| ECSP088536A (es) | DERIVADOS DE PIRIDO-, PIRAZO- Y PIRIMIDO-PIRIMIDINA COMO INHIBIDORES DE mTOR | |
| NZ597075A (en) | 1, 2, 4-thiazolidin-3-one derivatives as AMP-activated protein kinase (AMPK) agonists for treating cancer | |
| WO2005113747A3 (de) | Multizelluläre gewebe- und organkultursysteme | |
| WO2006058014A3 (en) | Harnessing network biology to improve drug discovery | |
| UA98629C2 (ru) | Соединения и способ модуляции киназ | |
| MY139942A (en) | Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors | |
| RU2711869C3 (ru) | Имидазопирролопиразиновые производные, полезные для лечения заболеваний, вызванных аномальной активностью протеинкиназ Jak1, Jak3 или Syk | |
| UY29826A1 (es) | Derivados de pirimidina, sales farmaceuticamente aceptables, esteres de los mismos hidrolisables in vivo, procesos de preparacion y aplicaciones | |
| NL2000375A1 (nl) | Pyrimidinederivaten voor de behandeling van abnormale celgroei. | |
| MY146112A (en) | Long-term feed - cancer patient | |
| TNSN07369A1 (en) | Heteroaryl urea derivatives useful for inhibiting chki | |
| DE602005019762D1 (de) | Medizinisches Instrument zum Manipulieren, insbesondere zum Zurückziehen des Gewebes oder des Organes. | |
| WO2006009765A3 (en) | Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells | |
| WO2010028373A3 (en) | Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients | |
| WO2007118751A3 (de) | Verfahren zur veränderung des atp-adp-verhältnisses in zellen | |
| IL186121A0 (en) | Substituted 1,5-naphthyridine azolidinones as cdk inhibitors | |
| EP4328319A3 (en) | Methods and compositions for identifying and treating patients with small cell lung cancer | |
| DE60004027D1 (de) | Organische-arsenverbindungen | |
| TW200731991A (en) | Lipophilic di(anticancer drug) compounds, compositions and related methods | |
| MY150745A (en) | Isoserine derivatives for use as coagulation factor ixa inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |